Different pro‐fibrotic growth factors and cytokines such as ET1, PDGF, IL‐6, and TGF‐β which are increased in skin and serum of SSc patients can enhance ECM production and differentiation of fibroblasts into myofibroblasts through activation of Ras signaling pathway [8, 9]. This evidence concerns the gene IL6 and systemic sclerosis.